Sanofi FY 2013 - Interview with CEO Chris Viehbacher

Sanofi, a global and diversified healthcare leader, reports annual results for 2013. CEO Chris Viehbacher comments on results and outlook.

Watch video interview and read transcript:

http://www.eurobusinessmedia.com/ceo-direct/sanofi/interview-with-ceo-chris-viehbacher-fy-2013,2014-02-05,1087?utm_source=ceo-direct&utm_medium=bw

Topics covered in the interview include:

- Q4 2013 Results
- 2014 Guidance
- Dividend
- Diabetes
- Vaccines
- Genzyme
- Emerging markets
- Pipeline

About Sanofi

Sanofi, an integrated global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

Company website: www.sanofi.com

Contacts:

Investor Relations:
SĂ©bastien Martel, +33 1 53 77 45 45
IR@sanofi.com
or
Media Relations:
+33 1 53 77 45 02
MR@sanofi.com

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.